The factory, in the coastal South African city of Gqeberha, formerly known as Port Elizabeth, was celebrated as a solution to the continent's unequal access to vaccines when it announced a deal to start manufacturing COVID-19 vaccines in November. But now it faces an imminent shut down if no orders are placed
JOHANNESBURG — The first factory in Africa licensed to produce COVID-19 vaccines for the African market has not received a single order and may shut down that production line within weeks if the situation doesn’t change, according to executives of the company, Aspen Pharmacare.
©2019 New York Times News Service